… not proceed, our primary focus at ProQR remains on our Axiomer ® RNA editing platform,” said Daniel A. de Boer, … is pioneering a next-generation RNA technology called Axiomer ® , which uses a cell’s own editing machinery called … in mind. Learn more about ProQR at www.proqr.com . About Axiomer® ProQR is pioneering a next-generation RNA base …
… Board (SAB). In vivo proof of concept data for novel Axiomer ® RNA editing platform technology presented at the … 1/2 trial of QR-110, announcing the in vivo PoC for our Axiomer technology and the completion of the pre-clinical … programs and our novel RNA-editing technology, Axiomer ® . We are also thrilled with the spin out of Amylon …
… transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced … please contact your Chardan representative. About Axiomer ® ProQR is pioneering a next-generation RNA base …
… transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced … 30 days following the presentation date. About Axiomer ® ProQR is pioneering a next-generation RNA base …
… Scientific Officer role, with leadership oversight of Axiomer ® RNA-editing platform technology John Maraganore, … to provide strategic oversight of ProQR’s proprietary Axiomer RNA-editing platform technology. He is the scientific … new strategy, including further building out the Company’s Axiomer RNA-editing technology as a value-generating …
… our earlier-stage pipeline candidates, and to advance our Axiomer ® and Trident ™ RNA-editing technology platforms.” … through intravitreal injections in the eye. About Axiomer and Trident ProQR is pioneering a next-generation RNA … yield a new class of medicines for genetic diseases. Axiomer “Editing Oligonucleotides”, or EONs, mediate single …